| 1 |
33747222 | Synergistic effects of olaparib combined with ERCC1 on the sensitivity of cisplatin in non-small cell lung cancer. | 2021 May |
2 |
| 2 |
30589644 | PARP inhibition enhances tumor cell-intrinsic immunity in ERCC1-deficient non-small cell lung cancer. | 2019 Mar 1 |
1 |
| 3 |
30797591 | ERCC1-XPF deficiency is a predictor of olaparib induced synthetic lethality and platinum sensitivity in epithelial ovarian cancers. | 2019 May |
2 |
| 4 |
23275151 | PARP inhibition selectively increases sensitivity to cisplatin in ERCC1-low non-small cell lung cancer cells. | 2013 Apr |
3 |